972 research outputs found
Head Shops - Legitimate Governmental Interest in Regulating the Sale of Drug Paraphernalia Receives Judicial Recognition
For the first time, the Supreme Court, in Village of Hoffman Estates v. Flipside, Hoffman Estates, Inc., rendered an opinion concerning the validity of a regulatory drug paraphernalia law, which was challenged as being impermissibly vague and overbroad. In Hoffman, a unanimous Court upheld the ruling of the District Court for the Northern District of Illinois and reversed the United States Court of Appeals for the Seventh Circuit. The court of appeals held that a municipal ordinance requiring businesses within the municipality to obtain a license if they sold any items designed or marketed for use with illegal cannabis or drugs was facially vague and overbroad. Since the challenged ordinance in Hoffman was regulatory in nature, at least one commentator has suggested that the ruling may be of minimal significance. This note will examine the decision rendered by the Court in Hoffman and its predictive value, if any, on the question of future facial challenges to drug paraphernalia laws
Head Shops - Legitimate Governmental Interest in Regulating the Sale of Drug Paraphernalia Receives Judicial Recognition
For the first time, the Supreme Court, in Village of Hoffman Estates v. Flipside, Hoffman Estates, Inc., rendered an opinion concerning the validity of a regulatory drug paraphernalia law, which was challenged as being impermissibly vague and overbroad. In Hoffman, a unanimous Court upheld the ruling of the District Court for the Northern District of Illinois and reversed the United States Court of Appeals for the Seventh Circuit. The court of appeals held that a municipal ordinance requiring businesses within the municipality to obtain a license if they sold any items designed or marketed for use with illegal cannabis or drugs was facially vague and overbroad. Since the challenged ordinance in Hoffman was regulatory in nature, at least one commentator has suggested that the ruling may be of minimal significance. This note will examine the decision rendered by the Court in Hoffman and its predictive value, if any, on the question of future facial challenges to drug paraphernalia laws
Charnel practices in medieval England: new perspectives
Studies of English medieval funerary practice have paid limited attention to the curation of human remains in charnel houses. Yet analysis of architectural, archaeological and documentary evidence, including antiquarian accounts, suggests that charnelling was more widespread in medieval England than has hitherto been appreciated, with many charnel houses dismantled at the sixteenth-century Reformation. The survival of a charnel house and its human remains at Rothwell, Northamptonshire permits a unique opportunity to analyse charnel practice at a medieval parish church. Employing architectural, geophysical and osteological analysis, we present a new contextualisation of medieval charnelling. We argue that the charnel house at Rothwell, a subterranean room constructed during the thirteenth century, may have been a particularly sophisticated example of an experiment born out of beliefs surrounding Purgatory. Our approach enables re-evaluation of the surviving evidence for charnel practice in England and enhances wider narratives of medieval charnelling across Europe
Exploiting catalytic chain transfer polymerization for the synthesis of carboxylated latexes via sulfurâfree RAFT
We present a systematic study of incorporating carboxyl groups into latex particles to enhance colloidal stability and the physical properties of the latex. Statistical copolymers of methacrylic acid and methyl methacrylate) were synthesized via catalytic chain transfer polymerization (CCTP) in emulsion. The vinylâterminated oligomers were in turn successfully utilized as chain transfer agents for the formation of diblock and pseudo triblock copolymers via sulfurâfree reversible additionâfragmentation chain transfer polymerization (SFâRAFT). These copolymers were characterized using 1H NMR, size exclusion chromatography (SEC), dynamic light scattering (DLS), dynamic mechanical analysis (DMA), contact angle measurements and matrixâassisted laser desorption/ionization time of flight mass spectroscopy (MALDIâTOFâMS) techniques. © 2019 Wiley Periodicals, Inc. J. Polym. Sci., Part A: Polym. Chem. 201
First results of a study of TeV emission from GRBs in Milagrito
Milagrito, a detector sensitive to Îł-rays at TeV energies, monitored the northern sky during the period February 1997 through May 1998. With a large field of view and high duty cycle, this instrument was used to perform a search for TeV counterparts to Îł-ray bursts. Within the Milagrito field of view 54 Îł-ray bursts at keV energies were observed by the Burst And Transient Satellite Experiment (BATSE) aboard the Compton Gamma-Ray Observatory. This paper describes the results of a preliminary analysis to search for TeV emission correlated with BATSE detected bursts. Milagrito detected an excess of events coincident both spatially and temporally with GRB 970417a, with chance probability 2.8Ă10â5 within the BATSE error radius. No other significant correlations were detected. Since 54 bursts were examined the chance probability of observing an excess with this significance in any of these bursts is 1.5Ă10â3. The statistical aspects and physical implications of this result are discussed
Milagro: A TeV observatory for gamma-ray bursts
Observation of prompt TeV Îł-rays from GRBs requires a new type of detector to overcome the low duty factor and small field of view of current TeV observatories. Milagro is such a new type of very high energy (\u3e a few 100 GeV) gamma-ray observatory, which has a large field of view of \u3e1 steradian and 24 hours/day operation. Milagrito, a prototype for Milagro, was operated from February 1997 to May 1998. During the summer of 1998, Milagrito was dismantled and Milagro was built. Both detectors use a 80âmĂ60âmĂ8âm pond of water in which a 3âmĂ3âm grid of photomultiplier tubes detects the Cherenkov light produced in the water by the relativistic particles in extensive air showers. Milagrito was smaller and had only one layer of photomultipliers, but allowed the technique to be tested. Milagrito observations of the Moonâs shadow and Mrk 501 are consistent with the Monte Carlo prediction of the telescopeâs parameters, such as effective area and angular resolution. Milagro will have improved flux sensitivity over Milagrito due to larger effective area, better angular resolution and cosmic-ray background rejection
Milagro: A TeV gamma-ray monitor of the Northern Hemisphere Sky
A new type of very high energy (\u3e a few 100 GeV) gamma-ray observatory, Milagro, has been built with a large field of view of \u3e1 steradian and nearly 24 hours/day operation. Milagrito, a prototype for Milagro, was operated from February 1997 to May 1998. During the summer of 1998, Milagrito was dismantled and Milagro was built. Both detectors use a 80âmĂ60âmĂ8âmpond of water in which a 3âmĂ3âm grid of photomultiplier tubes detects the Cherenkov light produced in the water by the relativistic particles in extensive air showers. Milagrito was smaller and had only one layer of photomultipliers, but allowed the technique to be tested. Milagrito observations of the Moonâs shadow and Mrk 501 are consistent with the Monte Carlo prediction of the telescopes parameters, such as effective area and angular resolution. Milagro is larger and consists of two layers of photomultiplier tubes. The bottom layer detects penetrating particles that are used to reject the background of cosmic-ray initiated showers
Results from the Milagrito experiment
The Milagro water Cherenkov detector near Los Alamos, New Mexico is the first air shower detector capable of continuously monitoring the sky at energies between 500 GeV and 20 TeV. Preliminary results of the Milagro experiment are presented. A predecessor of the Milagro detector, Milagrito, was operational from February 1997 to May 1998. Milagrito consisted of 228 8âł photomultiplier tubes (PMTs) arranged in a grid with a 2.8 meter spacing and submerged in 1â2 meters of water. During its operation, Milagrito collected in excess of 9 billion events with a median energy of about 3 TeV. The detectorâs sensitivity extends below 1 TeV for showers from near zenith. The results of an all sky search for the Milagrito data for both transient and DC sources will be presented, including the Crab Nebula and active galaxies Markarian 501 and 421, which are known sources of TeV gamma-rays. Also presented will be a study of the TeV emission from gamma ray bursts (GRBs) in Milagritoâs field of view detected by the BATSE experiment on the Compton Gamma-Ray Observatory
Recommended from our members
Cox-2 Inhibition Enhances the Activity of Sunitinib in Human Renal Cell Carcinoma Xenografts
Background: Sunitinib (Su), a tyrosine kinase inhibitor of VEGFR, is effective at producing tumour response in clear cell renal cell carcinoma (cRCC), but resistance to therapy is inevitable. As COX-2 is a known mediator of tumour growth, we explored the potential benefit of COX-2 inhibition in combination with VEGFR inhibition in attempts at delaying tumour progression on Su. Methods: COX-2 expression was compared with areas of hypoxia in tumours that progressed on Su vs untreated tumours. Mice bearing human cRCC xenografts were treated with Su and the COX-2 inhibitor, celecoxib, and the effects on tumour growth were assessed. Sequential vs concurrent regimens were compared. Results: COX-2 expression was increased in cRCC xenografts in areas of tumour hypoxia. The combination of Su and celecoxib achieved longer times to tumour progression compared to treatment with either agent alone or to untreated control animals in four models. This effect was seen with concurrent but not with sequential therapy. Conclusion: COX-2 inhibition can extend the effectiveness of VEGFR inhibition. This effect is dependent on the timing of therapy. Clinical trials combining Su and COX-2 inhibitors should be considered as a means delaying time to progression on sunitinib in patients with metastatic cRCC
- âŠ